CD8A and laryngeal squamous cell carcinoma: Moreover, compared with CD8+ T cells stimulated with untreated neutrophils, patient CD8+ T cells educated with LLL12-treated neutrophils presented a significantly greater killing capacity toward human laryngeal squamous cell carcinoma UT-SCC-50 tumor cells (Fig. 4e–g).